US2007166811A1PendingUtilityA1
Deracemisation of Amines
Est. expiryMar 19, 2022(expired)· nominal 20-yr term from priority
C12N 9/0022C12P 41/002
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are described for the deracemisation or chiral inversion of chiral amines by enzymatic treatment, such as by a stereoselective enzymatic conversion and either a non-selective or partially selective chemical or enzymatic conversion, simultaneously or sequentially. Also described are methods for selecting a suitable enzyme, particularly a suitable amine oxidase, and for the generation of novel enzymes suitable for use in the deracemisation method.
Claims
exact text as granted — not AI-modified1 . A method for the enantiomeric conversion of amines comprising treating a homochiral amine or a mixture of amine enantiomers with an enzyme capable of catalysing oxidation of the amine in a stereoselective manner and, subsequently or simultaneously, treating with a reducing agent.
2 . A method according to claim 1 which is a method of epimerisation of one single amine enantiomer to the other.
3 . A method according to claim 1 in which the mixture of amine enantiomers is a racemic mixture.
4 . A method according to claim 1 in which the reducing agent is partially enantioselective.
5 . A method according to claim 1 in which the reducing agent is a chemical reducing agent and is non-enantioselective.
6 . A method according to claim 5 in which the reducing agent is selected from sodium borohydride, sodium cyanoborohydride, an amine:borane complex or a transfer hydrogenation reagent.
7 . A method according to claim 6 in which the transfer hydrogenation reagent is ammonium formate with Pd/C.
8 . A method according to claim 6 in which the amine:borane complex is an ammonia:borane complex.
9 . A method according to claim 1 comprising an oxidation-reduction cycle in which the steps of treating with an enzyme capable of catalysing oxidation of the amine and treating with a reducing agent are performed sequentially, a plurality of times.
10 . A method of improving the activity, substrate specificity, or enantioselectivity of an amine oxidase enzyme by directed evolution, the method comprising mutation of the enzyme and selection of a mutant having improved activity against an homochiral substrate.
11 . A method of directing the evolution of an amino oxidase enzyme comprising the steps of:
a) mutating the enzyme to create at least one enzyme variant; b) screening said enzyme variant for activity against a homochiral substrate; and c) selecting one or more enzyme variants which show greater activity toward the substrate than does the originator enzyme.
12 . A method according to claim 11 , further comprising repeating steps a), b) and c) one or more times, using the enzyme variant selected in step c) as the enzyme to be mutated.
13 . A method according to claim 11 further comprising performing site directed mutagenesis on an enzyme selected in step c).
14 . A method according to claim 11 in which the enzyme is a monoamine oxidase.
15 . A method according to claim 14 in which the enzyme is a microbial monoamine oxidase.
16 . A method according to claim 15 in which the enzyme is the Aspergillus niger monoamine oxidase, or a variant thereof.
17 . A method according to claim 16 in which the enzyme is a variant of A. niger monoamine oxidase which differs from wild-type A. niger monoamine oxidase by mutation in the region of amino acids 334-350.
18 . A method according to claim 14 in which the enzyme is a variant of A. niger monoamine oxidase which differs from wild type A. niger monoamine oxidase by mutation of the amino acid at position number 336.
19 . A method according to claim 14 in which the enzyme is a variant of A. niger monoamine oxidase which differs from wild type A. niger monoamine oxidase by incorporation of the mutation: N336S.
20 .- 23 . (canceled)
24 . A method according to claim 1 in which said enzyme is an enantioselective monoamine oxidase (MAO) enzyme having the amino acid sequence of SEQ ID NO:2.
25 . A method according to claim 1 in which said enzyme is an enantioselective monoamine oxidase enzyme which is a variant of wild-type A. niger MAO, where said variant differs from wild-type A. niger monoamine oxidase by incorporation of the mutation: N336S.
26 . A method according to claim 1 in which said enzyme is an enantioselective monoamine oxidase enzyme which is a variant of wild-type A. niger MAO, where said variant differs from wild-type A. niger monoamine oxidase by incorporation of the mutations: N336S and M348K.
27 . A method according to claim 1 in which said enzyme is an enantioselective monoamine oxidase enzyme which is a variant of wild-type A. niger MAO, where said variant differs from wild-type A. niger monoamine oxidase by incorporation of the mutations: N336S and one or more of M348K, R259L and R260L.
28 . (canceled)Join the waitlist — get patent alerts
Track US2007166811A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.